Skip to main content
Premium Trial:

Request an Annual Quote

Milenia Labs to Distribute Cynvenio ClearID Breast Cancer Test in Mexico

NEW YORK (GenomeWeb) – Cynvenio Biosystems said today that it has made Milenia Labs the exclusive distributor of its ClearID Breast Cancer in Mexico.

Cynvenio's ClearID is a blood based assay for treatment selection and monitoring of advanced breast cancer patients. The complany's liquid biopsy technology analyzes circulating tumor cells and circulating cell-free DNA to detect gene alterations that are associated with resistance to a particular treatment. The test is intended for patients undergoing treatment for advanced disease and those who require follow-up testing at regular intervals after completion of therapy.

The agreement makes ClearID Breast Cancer available to customers through Milenia Labs and its network of 12 diagnostic centers in Mexico. Under the terms of the deal, Milenia will also offer Cynvenio’s PD-L1 gene expression reflex assay and other tests as they become commercially available.

Further terms of the agreement were not disclosed.

"Cynvenio's ClearID Breast Cancer test provides an excellent new option for patients based on state-of-the-art liquid biopsy technology that has the benefit of being more affordable compared to other tests in this category," Milenia Labs Director General Salvador Cardona said in a statement.

Cynvenio Chief Commercial Officer Humberto Huerta also noted that this deal is "the cornerstone of our plan to broaden access to ClearID Breast testing services outside the United States."

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.